Orange Book product · Brand (NDA)
LODOSYN
CARBIDOPA
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CARBIDOPA
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 017830
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023CARBIDOPAGeneric (ANDA)
ANDA 217961 · REGCON HOLDINGS
- 2019CARBIDOPAGeneric (ANDA)
ANDA 211055 · AUROBINDO PHARMA
- 2018CARBIDOPAGeneric (ANDA)
ANDA 209910 · ZYDUS PHARMS
- 2017CARBIDOPAGeneric (ANDA)
ANDA 204763 · NOVEL LABS INC
- 2016CARBIDOPAGeneric (ANDA)
ANDA 205304 · EDENBRIDGE PHARMS
- 2016CARBIDOPAGeneric (ANDA)
ANDA 204291 · ALVOGEN
- 2014CARBIDOPAGeneric (ANDA)
ANDA 203261 · ANI PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
